Cytomegalovirus retinitis in an ALL child on exclusive chemotherapy treated successfully with intravitreal ganciclovir alone

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 3, 2013, Pages

  Singh, Ramandeep ^a   Singh, Rishiraj ^a   Trehan, Amita ^a   Jain, Richa ^a   Bhalekar, Swapnil ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

ALL; CMV retinitis; Intravitreal ganciclovir

Indexed keywords

DEXAMETHASONE; GANCICLOVIR; MERCAPTOPURINE; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHILD; CYTOMEGALOVIRUS RETINITIS; DRUG PULSE THERAPY; DRUG RESPONSE; HEALING; HUMAN; HUMAN CELL; IRON DEFICIENCY ANEMIA; MAINTENANCE CHEMOTHERAPY; MALE; MONOTHERAPY; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; SCHOOL CHILD; SLIT LAMP; SYSTEMIC THERAPY; VISUAL ACUITY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; GANCICLOVIR; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; VISUAL ACUITY; VITREOUS BODY;

EID: 84876153474     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31827078ad     Document Type: Article

References (9)

1. Ghosh F, Hansson LJ, Bynke G, et al. Intravitreal sustainedrelease ganciclovir implants for severe bilateral cytomegalovirus retinitis after stem cell transplantation. Acta Ophthalmol Scand. 2002;80: 101-104.
2. Sherborne AL, Hemminki K, Kumar R, et al. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia. Haematologica. 2011;96: 1049-1054.
3. Baumal CR, Levin AV, Read SE. Cytomegalovirus retinitis in immunosuppressed children. Am J Ophthalmol. 1999;127: 550-558.
4. Mitchell CD, Richards SM, Kinsey SE, et al. On behalf of the Medical Research Council Childhood Leukemia Working Group. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol. 2005;129: 734-745.
5. Ng AP, Worth L, Chen L, et al. Cytomegalovirus DNAemia antigenemia and disease: incidence, natural history and management in settings other than allogenic stem cell transplantation. Hematologica. 2005;90: 1672-1679.
6. Guyotat D, Gibert R, Chomel J, et al. Incidence and prognosis of cytomegalovirus infections following allogenic bone marrow transplantation. J Med Virol. 1987;23: 393-399.
7. Kuo IC, John HK, James PD, et al. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. Am J Ophthalmol. 2004;138: 338-346.
8. Young S, Morlet N, Besen G, et al. High dose (2000-microgram) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis. Ophthalmology. 1998;105: 1404-1410.
9. Young S, McClusky P, Minnasian DC, et al. Retinal detachment in cytomegalovirus retinitis: intravenous versus intravitreal therapy. Clin Exp Ophthalmol. 2003;31: 196-202.